Skip to main content

Table 4 Association between inflammation at baseline and cognitive domains impaired at year 2

From: Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study

Inflammatory markers at baseline

Episodic memory (n = 200)

Working memory (n = 197)

Processing speed (n = 197)

Attention (n = 194)

Executive function (n = 196)

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

IL-6

5.50 (1.43 to 36.60)

0.03

0.98 (0.37 to 2.79)

0.97

1.47(0.68 to 3.30)

0.33

0.79 (0.24 to 2.58)

0.69

0.75 (0.34 to 1.73)

0.49

IL-8

0.94 (0.75 to 1.06)

0.51

0.93 (0.76 to 1.05)

0.42

0.96(0.85 to 1.04)

0.40

0.91 (0.79 to 1.03)

0.17

0.85 (0.69 to 0.98)

0.07

CRP > 3

2.59 (0.91 to 7.04)

0.07

1.23 (0.41 to 3.36)

0.70

2.47(1.05 to 5.87)

0.04

1.01 (0.24 to 4.04)

0.99

2.04 (0.81 to 4.92)

0.12

TNFα

1.25 (0.95 to 1.63)

0.09

0.64 (0.44 to 0.89)

0.01

1.03(0.83 to 1.26)

0.82

0.8 (0.53 to 1.16)

0.26

0.93 (0.72 to 1.19)

0.59

  1. Different model for each marker, adjusted on age, years of education, cognitive impairment at inclusion